Sepimostat

Drug Profile

Sepimostat

Alternative Names: FUT 187; TO 187

Latest Information Update: 20 Oct 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Taiho Pharmaceutical; Torii Pharmaceutical
  • Class Anti-inflammatories; Antiulcers; Benzoic acids
  • Mechanism of Action Peptide hydrolase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Pancreatitis; Reflux oesophagitis

Most Recent Events

  • 18 Dec 2000 Profile reviewed but no significant changes made
  • 08 Sep 1997 A study has been added to the pharmacokinetics section, to the Digestive System Disorders pharmacodynamics and Peptic Ulcer Disease therapeutic trials sections
  • 05 Sep 1997 Sepimostat is being investigated for use in pancreatitis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top